Alexandra F Bonthrone1, Raymond Stegeman2,3,4,5,6, Maria Feldmann7, Nathalie HP Claessens2,3,4,6, Maaike Nijman2,3,4,6, Nicolaas JG Jansen3,8, Joppe Nijman3, Floris Groenendaal2,6, Linda S de Vries2, Manon JNL Benders2, Felix Haas5, Mireille N Bekker9, Thushiha Logeswaran10, Bettina Reich11, Raimund Kottke12, Cornelia Hagmann13, Bea Latal7, Hitendu Dave14, John Simpson15, Kuberan Pushparajah15,16, Conal Austin15, Christopher J Kelly1, Sophie Arulkumaran1, Mary A Rutherford1, Serena J Counsell1, Walter Knirsch17, and Johannes MPJ Breur4
1Centre for the Developing Brain, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom, 2Department of Neonatology, Wilhelmina Children’s Hospital, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands, 3Department of Pediatric Intensive Care, Wilhelmina Children’s Hospital, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands, 4Department of Pediatric Cardiology, Wilhelmina Children’s Hospital, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands, 5Congenital Cardiothoracic Surgery, Wilhelmina Children’s Hospital, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands, 6Utrecht Brain Center, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands, 7Child Development Center, University Children's Hospital Zurich, Zurich, Switzerland, 8Department of Pediatrics, Beatrix Children’s Hospital, University Medical Center Groningen, Groningen, Netherlands, 9Department of Obstetrics, Wilhelmina Children’s Hospital, University Medical Center Utrecht and Utrecht University, Utrecht, Netherlands, 10Pediatric Heart Center, University Hospital Giessen, Justus-Liebig-University Giessen, Giessen, Germany, 11Department of Congenital Heart Disease and Pediatric Cardiology, German Heart Center Munich, Technical University of Munich, Munich, Germany, 12Department of Diagnostic Imaging, University Children’s Hospital Zurich, Zurich, Switzerland, 13Department of Neonatology and Pediatric Intensive Care, University Children’s Hospital Zurich, Zurich, Switzerland, 14Division of Congenital Cardiovascular Surgery, Pediatric Heart Centre, University Children’s Hospital Zurich, Zurich, Switzerland, 15Paediatric Cardiology Department, Evelina London Children's Healthcare, London, United Kingdom, 16Biomedical Engineering Department, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom, 17Pediatric Cardiology, Pediatric Heart Center, Department of Surgery, Children’s Research Center, University Children’s Hospital, and University of Zurich, Zurich, Switzerland
Synopsis
Infants with Congenital Heart Disease (CHD) are at risk of
neurodevelopmental impairments. MRI studies have identified brain injury in
infants with CHD both before and after cardiac surgery. We characterized risk
factors for preoperative and new postoperative arterial ischaemic stroke (AIS),
white matter injury (WMI) and cerebral sinovenous thrombosis (CSVT) in a cohort
of infants with severe CHD. Balloon atrial septostomy was associated with increased risk of
preoperative brain injury. Induced vaginal delivery was associated with preoperative WMI. Cardiac physiology and perioperative factors
were associated with increased risk of new postoperative brain injury.
Introduction
Infants with Congenital Heart Disease (CHD) are at
increased risk of neurodevelopmental impairments across multiple domains1,2.
The underlying mechanisms are unclear.
MRI studies have identified brain injury in infants
with CHD both before and after cardiac surgery3-5. White matter
injury (WMI) and arterial ischemic stroke (AIS) are the most commonly reported
lesions6-9. In addition, infants with CHD may also show cerebral
sinovenous thrombosis (CSVT) on perioperative MRI. Identification of modifiable
risk factors is essential to reduce brain injury. Our aim was to characterize
risk factors for preoperative and new postoperative AIS, WMI and CSVT in a
cohort of infants with CHD requiring cardiac surgery in the first six weeks
after birth.Methods
Three prospective
observational cohort studies from Wilhelmina Children’s Hospital Utrecht (WKZ
2016-2019), University Children’s Hospital Zurich (UCZ 2009-2019) and St
Thomas’ Hospital London (KCL 2014-2019) were combined. Infants with CHD [Median (25-75
quartile) gestational age at birth median= 39.0 (38.3-40.0) weeks] who underwent
corrective or palliative cardiac surgery during the first 6 weeks after birth
were included. CHD included in the study were transposition of the great
arteries (TGA) (with or without arch obstruction), single ventricle physiology
(SVP), or left ventricular outflow tract and/or aortic arch obstruction (LVOTO).
Infants with known or suspected genetic or syndromic disorders and other types
of CHD were excluded.
180 infants underwent a 3T brain MRI preoperatively,
146 of which were also imaged postoperatively. T1, T2, diffusion and
susceptibility-weighted images were acquired. Infants in WKZ and KCL also
underwent MR venography. MRI scans from each cohort were assessed using a
uniform description of brain imaging findings9. Clinical
characteristics were collected prospectively at each center and subsequently
combined. Postoperative brain MRI findings [Median (25-75
quartile) days from surgery= 10 (7-15)] were considered new if preoperative MRI
showed no corresponding findings, lesion(s) were in a different location,
and/or there was an increase in size or number compared to preoperative
findings. Potential risk factors (Table 1) for presence of WMI, AIS and CSVT
were assessed with univariate group differences and backward stepwise multivariate
logistic regressions. Input variables for the regression were selected based on
previous literature, outcomes from univariate analyses, and whether factors
were modifiable.Results
Examples of WMI, AIS and CSVT are given in Figure 1. The
number of infants who had WMI, AIS and CSVT pre- and postoperatively are summarized
in Table 2. Induced vaginal delivery (OR 2.23, 95% CI 1.06-4.70) was associated
with preoperative WMI. Balloon atrial septostomy was associated with WMI (OR
2.51, 95% CI 1.23-5.20) and AIS preoperatively (OR 4.49, 95% CI 1.20-21.49). Absolute
risk of preoperative WMI increased from 15% (95% CI 9%-24%) to 28% (95% CI
17%-43%) after induced vaginal delivery, 31% (95% CI 20%-44%) after balloon
atrial septostomy and 50% (95% CI 32%-68%) in infants who underwent both. The
absolute risk of preoperative AIS increased from 3% (95% CI 0.8%-8%) to 13%
(95% CI 6%-24%) after undergoing balloon atrial septostomy. SVP was a risk
factor for new postoperative WMI (OR 2.88 95% CI 1.20-6.95). Younger postnatal
age in days at surgery (OR 1.18, 95% CI 1.05-1.33) and selective cerebral
perfusion, particularly combined with deep hypothermia (≤20°C) (OR 13.46, 95%
CI 3.58-67.10), were independent risk factors for new postoperative AIS. Transposition
of the great arteries (OR 13.47, 95% CI 2.28-95.66) delayed sternal closure (OR
3.47 95% CI 1.08-13.06) and lower minimum intraoperative temperature (OR 1.22,
95% CI 1.07-1.36) were associated with new postoperative CSVT.Discussion
This study
confirms previous findings that balloon atrial septostomy is associated with
increased risk of preoperative brain injury10 and that infants with single
ventricle physiology are at higher risk for postoperative WMI8,11. Our
results suggest that delivery planning and timing of surgery encompass
modifiable risk factors that may allow clinicians to personalize treatment to
minimize the risk of perioperative brain injury in CHD. It is important to note in our centers,
balloon atrial septostomy is performed in infants with unacceptably low
preductal oxygen saturations. Infants who are delivered by planned induction
may be exposed to adverse intrauterine conditions. In addition, both induced
vaginal delivery and balloon atrial septostomy are utilized in infants who are susceptible
to cardiovascular disruption postnatally. We therefore cannot be certain
whether the interventions themselves or the associated indications increase
susceptibility to brain injury. Further research is needed to optimize
cerebral perfusion techniques for neonatal surgery and to confirm the
relationship between CSVT and perioperative risk factors.Acknowledgements
This
research was funded by a Consolidator Grant of the European Society of
Paediatric Research (ESPR). WKZ: Funding by the Hartekind
Foundation and Vrienden van het Wilhelmina Kinderziekenhuis Foundation and by
ZONMW (doelmatigheidsonderzoek) Crucial trial. KCL: Funding by
Action Medical Research (GN2630), the Medical Research Council UK (MR/V002465/1;
MR/L011530/1) and the British Heart Foundation
(FS/15/55/31649) and support from core funding
from the Wellcome/EPSRC Centre for Medical Engineering
[WT203148/Z/16/Z] and by the National Institute for Health Research (NIHR)
Biomedical Research Centre based at Guy’s and St Thomas’ NHS Foundation Trust
and King’s College London and/or the NIHR Clinical Research Facility. The views
expressed are those of the author(s) and not necessarily those of the NHS, the
NIHR or the Department of Health and Social Care. UCZ: Funding by
the Mäxi-Foundation, the Anna Müller Grocholski Foundation and the EMDO
Foundation Zurich. References
1. Marino BS, Lipkin PH, Newburger JW, et
al. Neurodevelopmental outcomes in children with congenital heart disease:
evaluation and management: a scientific statement from the American Heart
Association. Circulation 2012;126:1143–1172.
2. Feldmann M, Bataillard C, Ehrler M, et
al. Cognitive and Executive Function in Congenital Heart
Disease: A Meta-analysis. Pediatrics 2021;148:e2021050875.
3. Miller SP, McQuillen PS, Hamrick S, et
al. Abnormal brain development in newborns with congenital heart disease. N
Engl J Med 2007;357:1928–1938.
4. Mebius MJ, Kooi EMW, Bilardo CM, et al. Brain Injury and
Neurodevelopmental Outcome in Congenital Heart Disease: A Systematic Review.
Pediatrics 2017;140:e20164055.
5. Kelly CJ, Arulkumaran S, Tristão Pereira
C, et al. Neuroimaging findings in newborns with congenital heart disease prior
to surgery: an observational study. Arch Dis Child 2019;104:1042 LP – 1048.
6. Beca J, Gunn J, Coleman L, et al. Pre-Operative
Brain Injury in Newborn Infants With Transposition of the Great Arteries Occurs
at Rates Similar to Other Complex Congenital Heart Disease and Is Not Related
to Balloon Atrial Septostomy. J Am Coll Cardiol 2009;53:1807–1811.
7. Chen J, Zimmerman RA, Jarvik GP, Nord
AS, et al. Perioperative stroke in infants undergoing open heart
operations for congenital heart disease. Ann Thorac Surg 2009;88:823–829.
8. Beca J, Gunn JK, Coleman L, et al. New white matter
brain injury after infant heart surgery is associated with diagnostic group and
the use of circulatory arrest. Circulation 2013;127:971–979.
9. Stegeman R, Feldmann M, Claessens NHP, et al. A Uniform
Description of Perioperative Brain MRI Findings in Infants with Severe
Congenital Heart Disease: Results of a European Collaboration. Am J Neuroradiol
2021.
10. McQuillen PS, Hamrick SEG, Perez MJ,
Barkovich AJ, Glidden D V., Karl TR, et al. Balloon Atrial Septostomy Is
Associated With Preoperative Stroke in Neonates With Transposition of the Great
Arteries. Circulation 2006;113:280–285.
11. Peyvandi S, Kim
H, Lau J, Barkovich AJ, Campbell A, Miller S, et al. The association between
cardiac physiology, acquired brain injury, and postnatal brain growth in critical congenital heart
disease. J Thorac Cardiovasc Surg 2018;155:291-300.e3.
doi:10.1016/j.jtcvs.2017.08.019.